PMID- 1000483
OWN - NLM
STAT- MEDLINE
DCOM- 19770216
LR  - 20190619
IS  - 0008-543X (Print)
IS  - 0008-543X (Linking)
VI  - 38
IP  - 6
DP  - 1976 Dec
TI  - Early morning hydroxyproline excretion in patients with breast cancer.
PG  - 2564-6
AB  - The hydroxyproline/creatinine excretion ratios have been measured in half-hour
      fasting morning urine specimens from breast cancer patients and compared with
      corresponding values measured in 24 hour urine collections. Both parameters show 
      a close correlation. The value of the half-hour test in predicting the presence
      of early bone metastases, in monitoring the response of patients to therapy and
      in eliminating unwanted effects of dietary Hydroxyproline intake are discussed.
FAU - Powles, T J
AU  - Powles TJ
FAU - Rosset, G
AU  - Rosset G
FAU - Leese, C L
AU  - Leese CL
FAU - Bondy, P K
AU  - Bondy PK
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Cancer
JT  - Cancer
JID - 0374236
RN  - MU72812GK0 (Creatine)
RN  - RMB44WO89X (Hydroxyproline)
SB  - AIM
SB  - IM
MH  - Bone Neoplasms/diagnosis/urine
MH  - Breast Neoplasms/*urine
MH  - Creatine/urine
MH  - Female
MH  - Humans
MH  - Hydroxyproline/*urine
MH  - Neoplasm Metastasis
MH  - Time Factors
EDAT- 1976/12/01 00:00
MHDA- 1976/12/01 00:01
CRDT- 1976/12/01 00:00
PHST- 1976/12/01 00:00 [pubmed]
PHST- 1976/12/01 00:01 [medline]
PHST- 1976/12/01 00:00 [entrez]
AID - 10.1002/1097-0142(197612)38:6<2564::aid-cncr2820380648>3.0.co;2-w [doi]
PST - ppublish
SO  - Cancer. 1976 Dec;38(6):2564-6. doi:
      10.1002/1097-0142(197612)38:6<2564::aid-cncr2820380648>3.0.co;2-w.